🇺🇸 FDA
Patent

US 12201658

Viral gene therapy as treatment for cholesterol storage disease or disorder

granted A61KA61K35/761A61K48/005

Quick answer

US patent 12201658 (Viral gene therapy as treatment for cholesterol storage disease or disorder) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/761, A61K48/005, A61P, A61P25/28